NANX Nanophase Technologies Corp.

Nanophase Technologies Announces Third Quarter 2021 Financial Conference Call

Nanophase Technologies Announces Third Quarter 2021 Financial Conference Call

Nanophase Technologies Announces Third Quarter

2021 Financial Conference Call

Romeoville, IL, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Nanophase Technologies Corporation (OTCQB: NANX), a leader in minerals-based and scientifically-driven health care solutions across various beauty and life science categories — with innovations that protect skin from environmental aggressors and aid in medical diagnostics, today announced the Company will disseminate a financial news release for the third quarter 2021 on Wednesday, November 3, 2021, at 3:00 p.m. CDT, 4:00 p.m. EDT. The news release will be followed by the third quarter financial conference call on Thursday, November 4, 2021, at 10:00 a.m. CDT, 11:00 a.m. EDT.

Third Quarter 2021 Conference Call

The Nanophase conference call will be hosted by Jess Jankowski, the Company’s President & CEO. He will be joined by Kevin Cureton, the Company’s Chief Operating Officer. The call is scheduled for November 4, 2021, at 10:00 a.m. CDT, 11:00 a.m. EDT. The dial-in number for U.S. callers is 877-312-8776 and for international callers is 408-774-4007. The conference ID is 6190086. Please dial in to the conference at least five minutes before the call is scheduled to begin.

The call may also be accessed through the company’s website, at , by clicking on Investor Relations, Investor News, and the link in the conference call announcement release.

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), , is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated patented and proprietary technologies, the Company creates products with unique performance, enhancing consumers health and well-being. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.



Investor Relations
630-771-6700
EN
29/10/2021

Underlying

NANXNanophase Technologies Corp.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nanophase Technologies Corp.

 PRESS RELEASE
Free
NANX Nanophase Techn...

Solésence Reports Third Quarter 2025 Financial Results

Solésence Reports Third Quarter 2025 Financial Results Advances Strategic Transformation with Key Changes in Executive Leadership, Product Development and Operations ROMEOVILLE, Ill., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the third quarter ended September 30, 2025. Recent Highlights and Accomplishments Continued strategic transformation to drive future innovation and growth with promotion of Kevin Cureton to Pre...

November 11, 2025 1 EN
 PRESS RELEASE
Free
NANX Nanophase Techn...

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovatio...

Solésence, Inc. Appoints Yoana Dvorzsak as Vice President of Innovation and Product Integrity Dvorzsak to oversee product quality and drive innovation to support growth amidst evolving consumer needs; Named a Cosmetic Executive Women (CEW) Innovator Honoree ROMEOVILLE, Ill., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN) a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has appointed Yoana Dvorzsak to the newly created role of Vice President of Innovation and Product Integrity to support the Compan...

November 10, 2025 1 EN
 PRESS RELEASE
Free
NANX Nanophase Techn...

Solésence To Report Third Quarter 2025 Financial Results and Host a Co...

Solésence To Report Third Quarter 2025 Financial Results and Host a Conference Call ROMEOVILLE, Ill., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the third quarter of 2025 before the market opens on Tuesday, November 11, 2025, and host a conference call and webcast on the same date. Third Quarter 2025 Conference Call DetailsDate / Time: Tuesday, November 11, 2025 – 7:30 a.m. CDT, 8:30 a.m. EDT Speakers: Kevin Cu...

October 30, 2025 1 EN
 PRESS RELEASE
Free
NANX Nanophase Techn...

Solésence Announces Key Leadership Appointments to Drive Future Innova...

Solésence Announces Key Leadership Appointments to Drive Future Innovation and Growth Strategic transformation of Solésence continues with Kevin Cureton promoted to President and Chief Executive Officer; Laura Riffner named Chief Financial Officer; Jess Jankowski to serve as Board Advisor ROMEOVILLE, Ill., Sept. 03, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced strategic changes to its executive leadership. Kevin Cureton, a driving force behind the company’s expa...

September 3, 2025 1 EN
 PRESS RELEASE
Free
NANX Nanophase Techn...

Solésence Reports Second Quarter 2025 Financial Results

Solésence Reports Second Quarter 2025 Financial Results Strong commercial execution drove revenue growth of 56% to $20.4 million ROMEOVILLE, Ill., July 31, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the second quarter ended June 30, 2025.    Recent Highlights and Accomplishments Joined broad-market Russell 3000® and small-cap Russell 2000® IndexesAmended loan agreements to fuel growth initiatives “During our seasonally highest-pe...

July 31, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch